Clinical Roundup Blood test may help identify which colon cancer patients benefit from NSAIDs January 09, 2026Vol.52 No.1
Drugs & Targets FDA grants Enhertu Breakthrough Therapy designation as post-neoadjuvant therapy for HER2+ early breast cancer January 09, 2026Vol.52 No.1
Drugs & Targets China NMPA approves Pimicotinib as systemic treatment in tenosynovial giant cell tumor January 09, 2026Vol.52 No.1
Drugs & Targets Niowave expands global agreement with AstraZeneca for 10-year actinium-225 supply January 09, 2026Vol.52 No.1
Drugs & Targets Kallisio partners with Stanford Health Care on rollout of Stentra system for head-and-neck radiation therapy January 09, 2026Vol.52 No.1
Drugs & Targets SOPHiA GENETICS partners with MD Anderson on AI-driven precision oncology January 09, 2026Vol.52 No.1
Guest Editorial With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025 December 19, 2025Vol.51 No.46By Richard J. Jones
